• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Undiscovered Gems in Europe to Explore This July 2026

    Simply Wall St·07/24/2026 05:02:46
    Listen to the news

    As the European market navigates a period of volatility, with the pan-European STOXX Europe 600 Index showing little change amid tech sector weakness and geopolitical tensions, investors are keenly observing economic indicators such as inflation rates and industrial production figures. In this environment, identifying stocks that possess strong fundamentals and resilience to broader market fluctuations can be particularly rewarding for those exploring potential opportunities in Europe's diverse landscape.

    Top 10 Undiscovered Gems With Strong Fundamentals In Europe

    Name Debt To Equity Revenue Growth Earnings Growth Health Rating
    Zinzino NA 21.79% 32.66% ★★★★★★
    C-Rad NA 13.57% 13.83% ★★★★★★
    GROUPE SFPI 18.02% 4.25% -29.76% ★★★★★★
    Angler Gaming NA -5.12% -24.26% ★★★★★★
    IDI 2.16% -16.11% -24.28% ★★★★★☆
    VBG Group 41.41% 9.00% 6.26% ★★★★★☆
    Edel SE KGaA 142.35% 1.36% 12.24% ★★★★☆☆
    Bokusgruppen 25.20% 3.74% 19.78% ★★★★☆☆
    SP Group 85.48% 5.03% 8.16% ★★★★☆☆
    Jæren Sparebank 167.99% 11.94% 17.71% ★★★☆☆☆

    Click here to see the full list of 41 stocks from our European Undiscovered Gems With Strong Fundamentals screener.

    Here we highlight a subset of our preferred stocks from the screener.

    Angler Gaming (DB:0QM)

    Simply Wall St Value Rating: ★★★★★★

    Overview: Angler Gaming plc is a company that invests in online gaming service providers based in Malta, with a market capitalization of €313.44 million.

    Operations: Angler Gaming generates revenue primarily from iGaming activities, totaling €30.69 million. The company's net profit margin is a key financial metric to consider when evaluating its profitability.

    Angler Gaming, a nimble player in the European gaming sector, is making waves with its impressive earnings growth. The company reported a 154.4% increase in earnings over the past year, outpacing the Hospitality industry's 71.9% rise. Trading at an attractive 88.3% below estimated fair value, Angler seems to offer good relative value compared to peers and industry standards. With no debt on its books and strong non-cash earnings quality, Angler's financial health appears robust. Recent results show net income climbing to €2.52 million for Q1 2026 from €1.36 million last year, highlighting its potential for continued growth.

    DB:0QM Debt to Equity as at Jul 2026
    DB:0QM Debt to Equity as at Jul 2026

    RaySearch Laboratories (OM:RAY B)

    Simply Wall St Value Rating: ★★★★★★

    Overview: RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer treatment on a global scale, with a market cap of SEK5.64 billion.

    Operations: The company generates revenue primarily from its healthcare software segment, amounting to SEK1.30 billion.

    RaySearch Laboratories, a nimble player in the medical technology space, is making strides with its innovative cancer treatment software. Despite recent volatility in share price, the company trades at 57.8% below its estimated fair value and boasts no debt—a significant improvement from a 12.1% debt to equity ratio five years ago. Earnings have surged by an impressive 63.8% annually over the past five years, although recent growth of 0.3% lagged behind industry peers at 0.6%. With high-quality earnings and strong free cash flow of SEK 276 million as of September 2024, RaySearch seems well-positioned for future expansion amidst global demand for AI-enhanced oncology solutions.

    OM:RAY B Earnings and Revenue Growth as at Jul 2026
    OM:RAY B Earnings and Revenue Growth as at Jul 2026

    Voxel (WSE:VOX)

    Simply Wall St Value Rating: ★★★★★★

    Overview: Voxel S.A. operates in the healthcare sector, offering medical services in Poland, with a market capitalization of PLN 1.25 billion.

    Operations: Voxel's revenue is primarily driven by its Diagnostics segment, which includes medical services and sales of radiopharmaceuticals, generating PLN 451.79 million. The IT & Infrastructure segment contributes PLN 142.54 million through IT products and laboratory equipment sales. Therapy - Neuroradiosurgery adds PLN 15.70 million to the overall revenue stream.

    Voxel S.A., a notable player in the healthcare sector, showcases promising financials with earnings growing 14.1% annually over the past five years. Despite recent quarterly sales of PLN 157.19 million, slightly down from PLN 157.85 million last year, net income rose to PLN 31.9 million from PLN 24.27 million, indicating robust profitability and high-quality earnings. The company is trading at a significant discount of 57% below its estimated fair value and maintains a satisfactory net debt to equity ratio of 12.1%. With EBIT covering interest payments by an impressive margin of 17 times, Voxel's financial health appears strong as it continues to trade at good value compared to industry peers.

    WSE:VOX Debt to Equity as at Jul 2026
    WSE:VOX Debt to Equity as at Jul 2026

    Where To Now?

    Ready For A Different Approach?

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.